JILLIAN V DIETZ

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family HIGHLAND, IN NPI 1316214554

General Payments — all program years on this page

$823.13

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 46
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $226.97 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $226.9713

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $178.3810
Acerta Pharma LLC $33.712
GlaxoSmithKline, LLC. $14.881

By program year

Program yearAmountRecords
2021 $228.7315
2022 $199.6111
2023 $167.827
2024 $226.9713

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086799565 Novartis Pharmaceuticals Corporation $13.87 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086799567 Novartis Pharmaceuticals Corporation $22.01 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086799571 Novartis Pharmaceuticals Corporation $13.99 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086799573 Novartis Pharmaceuticals Corporation $21.42 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086799579 Novartis Pharmaceuticals Corporation $15.40 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086799581 Novartis Pharmaceuticals Corporation $1.14 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086799585 Novartis Pharmaceuticals Corporation $29.77 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086799587 Novartis Pharmaceuticals Corporation $19.42 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086799589 Novartis Pharmaceuticals Corporation $19.77 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086799591 Novartis Pharmaceuticals Corporation $21.59 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105242722 AstraZeneca Pharmaceuticals LP $17.06 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105403257 AstraZeneca Pharmaceuticals LP $16.65 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116403997 GlaxoSmithKline, LLC. $14.88 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.